Search

everythinglearnresearchcommunity

for

Search:↓

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Ritlecitinib is safe and may effectively treat alopecia areata.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

Oral baricitinib is effective and safe for treating alopecia areata.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Baricitinib is effective for severe alopecia areata but has some side effects.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Tridax procumbens has medicinal properties.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Tridax procumbens is a versatile herb with many health benefits.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

The new gel formulation for Acitretin improves topical delivery and reduces oral toxicity.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.